Cancer Clinical Trials in Austin, TX

A listing of Cancer Clinical Trials in Austin, TX actively recruiting patient volunteers.

Search by Name
Search
Filter by Condition
Cancer
5 trials found

TT-816 as Monotherapy or in Combination With a PD-1 Inhibitor in Patients With Advanced Cancers (SEABEAM) (MK3475-E88)

NCT05525455

A first-in-human study using TT-816 as a single agent and in combination with a PD-1 inhibitor in advanced cancers.

Conditions: Advanced Cancer, Advanced Solid Tumor, Cancer, Oncology
Phase: Phase 1/2

A Study in Patients With Advanced Cancers

NCT05320588

A first-in-human study using BIO-106 as a single agent and in combination with pembrolizumab in advanced cancers.

Conditions: Advanced Cancer, Advanced Solid Tumor, Cancer, Oncology
Phase: Phase 1/2

PATHFINDER 2: A Multi-Cancer Early Detection Study

NCT05155605

This is a prospective, multi-center interventional study of the GRAIL multi-cancer early detection (MCED) test with return of test results for participants enrolled through healthcare systems in North America. The purpose of this study is to evaluate the safety and performance of the GRAIL MCED test in a population of individuals who are eligible for guideline-recommended cancer screening. In cases with a "cancer signal detected" test result, participants will undergo diagnostic procedures based ...

Conditions: Early Detection of Cancer, Cancer
Phase: Not Applicable

A Study of OR2805, a Monoclonal Antibody Targeting CD163, Alone and in Combination With Anticancer Agents

NCT05094804

This is an open-label, multicenter, first-in-human dose-escalation and expansion Phase 1-2 study designed to determine the safety, tolerability, pharmacokinetics, pharmacodynamics, and preliminary anti-tumor activity of OR2805 administered as a monotherapy and in combination with anti-cancer agents in subjects with advanced solid tumors.

Conditions: Cancer, Tumor, Solid, Malignant Neoplasm, Metastatic Cancer, Advanced Solid Tumor, Non Small Cell Lung Cancer, Melanoma, Head and Neck Squamous Cell Carcinoma, Leiomyosarcoma, Liposarcoma
Phase: Phase 1/2

A Study of BMS-986253 in Combination With Nivolumab or Nivolumab Plus Ipilimumab in Advanced Cancers

NCT03400332

The purpose of this study is to investigate experimental medication BMS-986253 in combination with Nivolumab or Nivolumab plus Ipilimumab in participants with advanced cancers.

Conditions: Cancer, Melanoma
Phase: Phase 1/2